Effects of preoperative radiotherapy or chemoradiotherapy on postoperative pathological outcome of cervical cancer--from the large database of 46,313 cases of cervical cancer in China
- PMID: 31623897
- DOI: 10.1016/j.ejso.2019.09.188
Effects of preoperative radiotherapy or chemoradiotherapy on postoperative pathological outcome of cervical cancer--from the large database of 46,313 cases of cervical cancer in China
Abstract
Objective: To investigate the effect of preoperative radiotherapy or chemoradiotherapy combined with radical surgery on pathological outcomes in cervical cancer patients.
Methods: Based on a large Chinese cervical cancer database of clinical diagnosis and treatment (C4 Project), the postoperative pathological outcomes of patients who received preoperative radiotherapy or chemoradiotherapy followed by open surgery (PR group) or surgery alone (SD group) were compared.
Results: Among the strictly selected patients, the incidence of lymph node metastasis in the PR group (n = 574) was higher than that in the SD group (231 VS 9; P < 0.001), while the incidence of vascular space invasion was lower than that in the SD group (72 VS 2041; P < 0.001). The logistic regression analysis showed that preoperative radiotherapy was a protective factor for parametrial involvement, positive surgical margins, deep cervical stromal invasion, and vascular space invasion (P < 0.05). The median number of resected lymph nodes in both groups was 18. After 1:1 case matching, the incidence of deep cervical stromal invasion and vascular space invasion was reduced by preoperative radiotherapy (292 vs 376, P < 0.001; 60 vs 106, P < 0.001). Logistic regression analysis indicated that preoperative radiotherapy was a protective factor for deep cervical stromal invasion and vascular space invasion (P < 0.05). The median numbers of resected lymph nodes in the two groups were 18 and 19, separately.
Conclusion: Preoperative radiotherapy can reduce both the incidence of deep cervical stromal invasion and vascular space invasion, but it cannot reduce lymph node positivity, parametrial involvement and positive surgical margins.
Keywords: Cervical cancer; Pathology; Radiotherapy; Radiotherapy and chemotherapy.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
Similar articles
-
Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):420-7. doi: 10.1016/j.ijrobp.2011.12.013. Epub 2012 Feb 24. Int J Radiat Oncol Biol Phys. 2012. PMID: 22365621
-
Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.Am J Clin Oncol. 2016 Feb;39(1):37-42. doi: 10.1097/COC.0000000000000011. Am J Clin Oncol. 2016. PMID: 25734407
-
Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.J BUON. 2007 Jan-Mar;12(1):57-63. J BUON. 2007. PMID: 17436403
-
Strategies for the Treatment of Cervical Cancer with Bulky Pelvic Lymph Nodes: An Overview of the Current Evidence.J UOEH. 2020;42(4):317-325. doi: 10.7888/juoeh.42.317. J UOEH. 2020. PMID: 33268608 Review.
-
Adjuvant treatment in cervical, vaginal and vulvar cancer.Best Pract Res Clin Obstet Gynaecol. 2022 Jan;78:36-51. doi: 10.1016/j.bpobgyn.2021.07.005. Epub 2021 Aug 5. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 34426088 Review.
Cited by
-
Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.Ann Transl Med. 2022 Jan;10(2):121. doi: 10.21037/atm-21-6367. Ann Transl Med. 2022. PMID: 35282114 Free PMC article.
-
Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer-A Propensity Score Matching Analysis.Front Oncol. 2021 Sep 13;11:730753. doi: 10.3389/fonc.2021.730753. eCollection 2021. Front Oncol. 2021. PMID: 34589433 Free PMC article.
-
Uterine corpus invasion in cervical cancer: a multicenter retrospective case-control study.Arch Gynecol Obstet. 2021 Mar;303(3):777-785. doi: 10.1007/s00404-021-05968-1. Epub 2021 Feb 5. Arch Gynecol Obstet. 2021. PMID: 33544202
-
Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study.Arch Gynecol Obstet. 2022 Feb;305(2):449-458. doi: 10.1007/s00404-021-06185-6. Epub 2021 Aug 18. Arch Gynecol Obstet. 2022. PMID: 34406459
-
Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.Acta Obstet Gynecol Scand. 2023 Aug;102(8):1045-1052. doi: 10.1111/aogs.14612. Epub 2023 Jun 20. Acta Obstet Gynecol Scand. 2023. PMID: 37338046 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous